Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6520
    +0.0020 (+0.31%)
     
  • OIL

    82.96
    +0.15 (+0.18%)
     
  • GOLD

    2,333.50
    -4.90 (-0.21%)
     
  • Bitcoin AUD

    98,581.43
    -3,850.72 (-3.76%)
     
  • CMC Crypto 200

    1,389.17
    +6.59 (+0.48%)
     
  • AUD/EUR

    0.6080
    +0.0009 (+0.15%)
     
  • AUD/NZD

    1.0952
    +0.0010 (+0.09%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    0.00 (0.00%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,271.15
    +69.88 (+0.41%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Asian Stocks Up Despite COVID-19 Uncertainty

By Gina Lee

Investing.com – Asian stock markets were up on Tuesday with modest gains despite the economic uncertainty unleashed by the COVID-19 pandemic.

Japan’s Nikkei 225 rose 1.89% by 10:23 PM ET (3:23 AM GMT). Conglomerate Softbank Group (T:9984) saw its shares gain 2.95% as they rallied from an earlier drop of more than 3% the day before. The company announced that its Vision Fund expected to see a loss of JPY 1.8 trillion ($16.69 billion) for the 2019 fiscal year due to a “deteriorating market environment.”

China’s Shanghai Composite was up 0.57% while the Shenzhen Component was up 0.93%. with Chinese trade data for March set to be released later in the day.

ADVERTISEMENT

Investors will be taking a close look at the data as Wuhan lifted its three-month lockdown in the previous week.

South Korea’s KOSPI gained 1.6% as the country prepares to vote for its National Assembly representatives on Wednesday.

The S&P/ASX 200 rose 0.49% and Hong Kong’s Hang Seng Index was up by 0.4% as investors resumed work from the four-day Easter weekend.

But some investors are skeptical as companies enter into a difficult earnings seasons and governments assess the pandemic’s economic damage as the search for a cure continues.

“Companies, analysts, traders, investors and strategists to some extent are ‘flying into earnings season without instruments,’” John Stoltzfus, chief investment strategist at Oppenheimer&Co., told Bloomberg. “The unprecedented nature of the economic shutdown, social distancing and sheltering in place ordered by officials provides an overhang of uncertainty.”

Related Articles

Disney enters $5 billion credit agreement

Exxon raises $9.5 billion to load up on cash while debt market still open to new deals

Asia shares jump but pandemic hangs heavy over outlook